Netarsudil/latanoprost

Netarsudil/latanoprost, sold under the brand name Rocklatan, is a fixed-dose combination medication use to treat elevated intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.[2] It contains netarsudil mesylate and latanoprost.[2] It is applied as eye drops to the eyes.[2]

Netarsudil/latanoprost
Combination of
NetarsudilRho kinase inhibitor
LatanoprostProstaglandin F2α analogue
Clinical data
Trade namesRocklatan
AHFS/Drugs.comProfessional Drug Facts
License data
Pregnancy
category
  • US: N (Not classified yet) [1]
    Routes of
    administration    		Topical eye drops
    ATC code
    Legal status
    Legal status
    Identifiers
    UNII
    KEGG

    It was approved for medical use in the United States in March 2019.[3]

    See also
    • Netarsudil/latanoprost

    References
    1. "Latanoprost / netarsudil ophthalmic (Rocklatan) Use During Pregnancy". Drugs.com. 1 April 2019. Retrieved 2 June 2020.
    2. "Rocklatan- netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% solution/ drops". DailyMed. 10 March 2020. Retrieved 2 June 2020.
    3. "Drug Approval Package: Rocklatan Ophthalmic Solution". U.S. Food and Drug Administration (FDA). 20 November 2019. Retrieved 2 June 2020.
    • "Netarsudil". Drug Information Portal. U.S. National Library of Medicine.
    • "Latanoprost". Drug Information Portal. U.S. National Library of Medicine.


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.